Press release
Neuroendocrine Cancer Market: Rising Prevalence of Neuroendocrine Cancer and Growing at the Highest CAGR
Neuroendocrine Cancer Market Segmentation Analysis
Total Neuroendocrine Cancer Studies: 2499
By Drug Type
Everolimus
Sunitinib Malate
Lanreotide
Octreotide
Others
Sunitinib (Sutent) and Everolimus (Afinitor) are two major targeted drugs that are being used for the treatment of neuroendocrine cancer.
By Treatment
Surgery
Chemotherapy
Targeted Therapy
Radiotherapy
Other Medications
The operation is the primary treatment for Neuroendocrine cancer accounted for the largest market share followed by Chemotherapy.
By End User
Hospitals
Oncology Centers
Others
Request for the free sample of the report - https://www.datamintelligence.com/research-report/neuroendocrine-cancer-market
Neuroendocrine Cancer Market Geographical Share
The market is segmented geographically into North America, South America, Europe, Asia-Pacific, and RoW. North America is dominating the global Neuroendocrine cancer market.
According to Cancer.Net, approx. It is estimated that more than 12,000 people in the United States are diagnosed with a neuroendocrine tumour each year. Also, several major players in neuroendocrine cancer market are based in the U.S and therefore consider North America is a has the highest market share with new product launch and research and development investments. With the rising prevalence of neuroendocrine cancer in the Asia-Pacific, the market is growing at the highest CAGR.
Neuroendocrine Cancer Market Competitive Analysis
The major players of global Neuroendocrine Cancer market include Advanced Accelerator Applications, Novartis AG, Hutchison Medipharma Ltd, Dauntless Pharmaceuticals Inc., Aspen, Tarveda Therapeutics, Exelixis, and Pfizer Inc.
Table of contents overview -
1. Neuroendocrine Cancer market – Methodology and Scope
2. Neuroendocrine Cancer market – Executive Summary
3. Neuroendocrine Cancer market – Industry Analysis
4. Global Neuroendocrine Cancer Market – Epidemiology
5. Global Neuroendocrine Cancer Market -Product Pipeline Analysis
6. Global Neuroendocrine Cancer Market -Clinical Trail Analysis
7. Segmentation by Drug Type
8. Segmentation by Treatment
9. Segmentation by End-User
10. Geographical Analysis
11. Competitive Landscape
12. Company Profiles*
Read more information about the report - https://www.datamintelligence.com/research-report/neuroendocrine-cancer-market
Corporate Address
1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana
info@datamintelligence.com
Phone
+1 877-441-4866
About DataM Intelligence
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.
Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. This approach not only aligns the findings with historical data but also allows a highly justifiable forecast model.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuroendocrine Cancer Market: Rising Prevalence of Neuroendocrine Cancer and Growing at the Highest CAGR here
News-ID: 1787661 • Views: …
More Releases from DataM Intelligence 4Market Research
United States ECG Telemetry Devices Market Poised for Robust Growth Amid Rising …
Market Overview:
The Global ECG Telemetry Devices Market is estimated to grow at a CAGR of 8% during the forecast period 2024-2031.
The ECG Telemetry Devices Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative…
United States Graphene Battery Market Poised for Explosive Growth as Demand for …
Market Overview:
The Graphene Battery Market is estimated to reach at a CAGR of 23.9% during the forecast period (2024-2031).
The Graphene Battery Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it…
United States Oligonucleotide Therapy Market Set for Breakthrough Growth with Ri …
Market Size and Growth:
The Oligonucleotide Therapy Market was valued at USD 6,533.09 million in 2024 and is projected to reach USD 24,462.21 million by 2033, growing at a CAGR of 15.8% during the forecast period (2025-2033).
The Oligonucleotide Therapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
United States Phytosterols Market Set for Strong Growth Driven by Rising Demand …
Market Overview:
The Phytosterols Market is expected to reach at a CAGR of 8.2% during the forecast period 2024-2031.
The Phytosterols Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive…
More Releases for Neuroendocrine
Neuroendocrine Carcinoma Market Massive Growth opportunity Ahead
Introduction
Neuroendocrine carcinoma (NEC) is a rare and aggressive form of cancer that arises from neuroendocrine cells, which are found throughout the body and are responsible for producing hormones. These tumors can occur in various organs, including the lungs, pancreas, liver, and gastrointestinal tract. Due to its often vague and non-specific symptoms, neuroendocrine carcinoma is frequently diagnosed at an advanced stage, making it challenging to treat effectively.
In recent years, however, there…
Rising Neuroendocrine Tumors Fuel Treatment Market Growth Driving Market Acceler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Neuroendocrine Tumor Treatment Market Size By 2025?
The industry for treating neuroendocrine tumors has witnessed substantial growth in the previous years. The market size is projected to escalate from $2.17 billion in 2024 to $2.4 billion in 2025, with a compound annual growth rate (CAGR)…
Emerging Trends Influencing The Growth Of The Neuroendocrine Tumor Treatment Mar …
The Neuroendocrine Tumor Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Neuroendocrine Tumor Treatment Market Size Expected to Be by 2034?
The market for neuroendocrine tumor treatment has seen a significant expansion in recent years. Projected to grow from a value…
Prominent Neuroendocrine Tumor Treatment Market Trend for 2025: Clinical Trials …
How Are the key drivers contributing to the expansion of the neuroendocrine tumor treatment market?
The neuroendocrine tumor treatment market is forecasted to expand due to the increasing incidence of neuroendocrine tumors. Neuroendocrine tumors, or NETs, are rare growths that begin in neuroendocrine cells, and their treatment is vital to managing the symptoms, controlling the tumor's growth, and applying radiation therapy to destroy the cancerous cells. The American Society of Clinical…
Neuroendocrine Tumor Treatment Market – Forecast to 2026
According to a new market research report published by Global Market Estimates, the Global Neuroendocrine Tumor Treatment Market is projected to grow from USD 1.8 billion in 2021 to USD 2.1 billion by 2026 at a CAGR value of 5.7% between 2021 to 2026. High prevalence of neuropsychiatric malignancy, awareness regarding early cancer diagnosis, and an increasing number of government initiatives, the neuroendocrine tumor therapy market is expected to rise…
Global Neuroendocrine Tumor Treatment Market
The Global Neuroendocrine Tumor Treatment Market was valued at US$ 1,197.3 million in 2016 and is projected to expand at a CAGR of 10.5% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Better diagnostic techniques and products in pipeline are expected to be major factors driving growth of the global neuroendocrine tumor treatment market over the foreseeable future.
Neuroendocrine Tumor (NET) are diagnosed…
